Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-12-01T08:51:25.092Z Has data issue: false hasContentIssue false

9 - Fetal dysmorphology: the role of the geneticist in the fetal medicine unit in targeting diagnostic tests

Published online by Cambridge University Press:  05 February 2014

Tessa Homfray
Affiliation:
St George's University
Sean Kehoe
Affiliation:
John Radcliffe Hospital, Oxford
Lyn Chitty
Affiliation:
University College Hospital, London
Tessa Homfray
Affiliation:
St George’s University of London
Get access

Summary

Introduction

A clinical geneticist can have several roles in a fetal medicine unit: assisting with management of the family at high risk of a genetic condition, aiding the interpretation of complex chromosome rearrangements and facilitating the diagnosis of a fetus with structural anomalies but apparently normal chromosomes. With increasing routine use of prenatal sonography for the diagnosis of fetal anomalies and the technological improvements in ultrasound machines, more fetal abnormalities are being detected. Defining the prognosis for a fetus with structural abnormalities if the karotype is abnormal can be reasonably straightforward but cases with apparently normal chromosomes are more challenging. Accurate prenatal diagnosis of rare syndromes is becoming an increasing reality with the advances in ultrasonography and molecular technology. Such accuracy is not always possible prenatally, and postnatal confirmation is thus essential.

For the past two decades, increasing numbers of gene mutations have been identified that allow invasive prenatal diagnosis in subsequent pregnancies in early gestation, giving parents in many countries around the world choices in the management of affected pregnancies. This does, however, require a couple to have a family history of a disorder, with accurate confirmation of the diagnosis, usually before pregnancy. In the absence of a family history, an abnormality will only be identified by a screening test. Screening tests during pregnancy fall into two groups:

  1. ■ those identified on blood tests, such as sickle cell trait, and first- and second-trimester biochemical screening for Down syndrome

  2. ■ those identified on ultrasound.

Type
Chapter
Information
Reproductive Genetics , pp. 131 - 146
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×